Upgrade to SI Premium - Free Trial

Virgin Galactic Announces Fourth Quarter and Full Year 2020 Financial Results

February 25, 2021 4:05 PM

Rollout of Second Spaceship Scheduled to Take Place on March 30

Announced Expected Timing of Revenue-Generating Flight with the Italian Air Force

Next Rocket-Powered Spaceflight Targeted to Occur in May

LAS CRUCES, N.M.--(BUSINESS WIRE)-- Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the “Company”), a vertically integrated aerospace and space travel company, today announced its financial results for the fourth quarter and full year ended December 31, 2020.

“We accomplished several significant milestones during 2020 despite the ongoing challenges posed by the COVID-19 pandemic,” said Michael Colglazier, Chief Executive Officer of Virgin Galactic. “Looking ahead, we’re focused on completing our test flight program, expanding our fleet of spaceships and motherships, and developing our unique and transformative customer experience. I am excited about the talent we’re bringing on to our leadership team and the investments we’re making in the business, both of which will position us well to scale for future growth.”

Fourth Quarter 2020 Business Highlights:

Fourth Quarter 2020 Financial Highlights:

Recent Updates:

COVID-19 Impact

The Company is continuing to experience ongoing delays to its business and operations due to COVID-19. The Company continues to operate under strict protocols and follows rigorous health and safety procedures, in line with CDC, state and local guidelines, to ensure employee safety.

Conference Call Information

Virgin Galactic will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today. To access the conference call, parties should dial (778) 560-2846 and enter the conference ID number 4979998. The live audio webcast along with accompanying presentation materials will be accessible on the Company’s Investor Relations website at investors.virgingalactic.com. A recording of the webcast will also be available following the conference call.

About Virgin Galactic Holdings

Virgin Galactic Holdings, Inc. is a vertically integrated aerospace and space travel company, pioneering human spaceflight for private individuals and researchers, as well as a manufacturer of advanced air and space vehicles. It is developing a spaceflight system designed to offer customers a unique and transformative experience. You can find more information at https://www.virgingalactic.com/.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of federal securities laws with respect to Virgin Galactic Holdings, Inc. (the "Company"), including statements regarding the Company’s expected spaceship rollout and flight schedule. These forward-looking statements generally are identified by words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this presentation, including but not limited to the factors, risks and uncertainties included in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including, once filed, its Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which are or will be accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.virgingalactic.com. These filings identify and address other important risks and uncertainties that could cause the Company’s actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Fourth Quarter 2020 Financial Results

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands except for per share data)

Three Months Ended

Year Ended

(unaudited)

(unaudited)

December 31,
2020

September 30,
2020

December 31,
2019

December 31,
2020

December 31,
2019

Revenue

$

$

$

529

$

238

$

3,781

Cost of revenue

314

173

2,004

Gross profit

215

65

1,777

Selling, general, and administrative expenses

32,854

30,936

37,447

116,592

82,166

Research and development expenses1

41,463

46,095

36,754

158,757

132,873

Operating loss

(74,317

)

(77,031

)

(73,986

)

(275,284

)

(213,262

)

Interest income

272

322

1,160

2,277

2,297

Interest expense

(10

)

(9

)

(34

)

(36

)

(36

)

Other income (expense)

9

(44

)

14

128

Loss before income taxes

(74,046

)

(76,762

)

(72,860

)

(273,029

)

(210,873

)

Income tax (benefit) expense

(28

)

40

(61

)

6

62

Net loss

(74,018

)

(76,802

)

(72,799

)

(273,035

)

(210,935

)

Other comprehensive loss:

Foreign currency translation adjustment

(48

)

48

56

(54

)

(23

)

Total comprehensive loss

$

(74,066

)

$

(76,754

)

$

(72,743

)

$

(273,089

)

$

(210,958

)

Net loss per share:

Basic and diluted

$

(0.31

)

$

(0.34

)

$

(0.37

)

$

(1.25

)

$

(1.09

)

Weighted-average shares outstanding:

Basic and diluted

236,722,884

225,253,536

194,378,154

219,107,905

194,378,154

1Please refer to Reclassification section for prior period adjustment.

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Balance Sheets

(In thousands, except share data)

As of

December 31,
2020

December 31,
2019

(unaudited)

Assets

Current assets

Cash and cash equivalents

$

665,924

$

480,443

Restricted cash

13,031

12,278

Accounts receivable

470

461

Inventories1

30,483

31,855

Prepaid expenses and other current assets

17,949

16,672

Due from related party, net

70

Total current assets

727,927

541,709

Property, plant, and equipment, net1

53,148

44,295

Right-of-use asset

19,914

16,927

Other non-current assets

3,001

2,615

Total assets

$

803,990

$

605,546

Liabilities and Stockholders' Equity

Current liabilities

Accounts payable

$

5,998

$

7,038

Current portion of operating lease obligation

2,384

2,354

Current portion of finance lease obligation

136

47

Current portion of note payable

310

Accrued expenses

22,982

22,277

Customer deposits

83,211

83,362

Due to related party, net

767

Total current liabilities

115,021

115,845

Finance lease obligation, net of current portion

236

274

Operating lease obligation, net of current portion

24,148

21,867

Note payable, net of current portion

310

Other long-term liabilities

1,757

Total liabilities

$

141,472

$

137,986

Stockholders' Equity

Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding

$

$

Common stock, $0.0001 par value; 700,000,000 shares authorized; 236,123,659 and 196,001,038 shares issued and outstanding as of December 31, 2020 and 2019, respectively

23

20

Additional paid-in capital

1,057,202

589,158

Accumulated deficit

(394,712)

(121,677)

Accumulated other comprehensive income

5

59

Total stockholders' equity

662,518

467,560

Total liabilities and stockholders' equity

$

803,990

$

605,546

1Please refer to Reclassification section for prior period adjustment.

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(In thousands)

Three Months Ended

Year Ended

(unaudited)

(unaudited)

December
31, 2020

September
30, 2020

December
31, 2019

December
31, 2020

December
31, 2019

Cash flows from operating activities

Net loss

$

(74,018

)

$

(76,802

)

$

(72,799

)

$

(273,035

)

$

(210,935

)

Stock-based compensation

11,749

8,625

2,535

30,324

2,535

Depreciation and amortization

2,765

2,529

2,079

9,781

6,999

Deferred rent

375

(Gain) Loss on disposal of property and equipment1

21

8

(555

)

96

(555

)

Change in assets and liabilities

Accounts receivable

(100

)

414

431

(106

)

819

Inventories1

176

3,182

(6,256

)

1,371

(8,566

)

Prepayments and other current assets

(8,674

)

4,724

(13,089

)

(342

)

(12,476

)

Other non-current assets

47

(1,251

)

8,107

(1,131

)

1,178

Due from related party, net

158

(996

)

9,734

(838

)

9,734

Accounts payable and accrued expenses

(1,729

)

1,633

(2,883

)

(1,010

)

(323

)

Customer deposits

21

1,456

1,160

(151

)

2,479

Other current and non-current liabilities

(512

)

1,502

(9,664

)

1,882

Net cash used in operating activities

(70,096

)

(54,976

)

(80,825

)

(233,159

)

(209,111

)

Cash flows from investing activity

Capital expenditures1

(3,540

)

(3,721

)

(176

)

(17,201

)

(13,856

)

Cash used in investing activity1

(3,540

)

(3,721

)

(176

)

(17,201

)

(13,856

)

Cash flows from financing activities

Payments of finance lease obligations

(34

)

(40

)

(49

)

(123

)

(104

)

Repayment of notes payable

(310

)

(310

)

Net transfer from Parent Company

106,119

Proceeds from Parent Company

16,310

56,310

Proceeds from issuance of common stock pursuant to stock options exercised

2,582

2,582

Proceeds from issuance of common stocks

460,200

20,000

460,200

20,000

Proceeds from reverse acquisition

500,000

500,000

Transaction costs

(122

)

(19,399

)

(48,005

)

(20,988

)

(48,005

)

Withholding taxes paid on behalf of employee on net settled stock-based awards

(4,368

)

(399

)

(4,767

)

Net cash provided by (used in) by financing activities

(2,252

)

440,362

488,256

436,594

634,320

Net increase (decrease) in cash and cash equivalents1

(75,888

)

381,665

407,255

186,234

411,353

Cash, cash equivalents and restricted cash at beginning of period

754,843

373,178

85,466

492,721

81,368

Cash, cash equivalents and restricted cash at end of period

$

678,955

$

754,843

$

492,721

$

678,955

$

492,721

Cash and cash equivalents

$

665,924

$

741,575

$

480,443

$

665,924

$

480,443

Restricted cash

13,031

13,268

12,278

13,031

12,278

Cash, cash equivalents and restricted cash

$

678,955

$

754,843

$

492,721

$

678,955

$

492,721

1Please refer to Reclassification section for prior period adjustment.

Use of Non-GAAP Financial Measures (Unaudited)

This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (GAAP), including Adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines Adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general, and administrative expenses as selling, general, and administrative expenses other than stock-based compensation and non-capitalized transaction costs, and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with GAAP and should not be considered as an alternative to any other performance measures derived in accordance with GAAP.

The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.

A reconciliation of Adjusted EBITDA to net loss for the three months ended December 31, 2020, September 30, 2020, December 31, 2019 and years ended December 31, 2020 and 2019, respectively, are set forth below:

(In thousands)

Three Months Ended

Year Ended

December
31, 2020

September
30, 2020

December
31, 2019

December
31, 2020

December
31, 2019

Net Loss

$

(74,018

)

$

(76,802

)

$

(72,799

)

$

(273,035

)

$

(210,935

)

Income tax (benefit) expense

(28

)

40

(61

)

6

62

Interest expense

10

9

34

36

36

Depreciation & amortization

2,765

2,529

2,079

9,781

6,999

EBITDA

(71,271

)

(74,224

)

(70,747

)

(263,212

)

(203,838

)

Cash Incentive Plan Disbursement

9,867

9,867

Non-capitalized transaction costs*

3,577

697

4,692

Stock-based compensation

11,749

8,625

2,535

30,324

2,535

Adjusted EBITDA

$

(59,522

)

$

(65,599

)

$

(54,768

)

$

(232,191

)

$

(186,744

)

A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended December 31, 2020, September 30, 2020, December 31, 2019 and years ended December 31, 2020 and 2019, respectively, are set forth below:

(In thousands)

Three Months Ended

Year Ended

December
31, 2020

September
30, 2020

December
31, 2019

December
31, 2020

December
31, 2019

Selling, general, and administrative expenses

$

32,854

$

30,936

$

37,447

$

116,592

$

82,166

Cash Incentive Plan Disbursement

9,867

9,867

Stock-based compensation

9,800

5,056

1,591

21,272

1,591

Non-capitalized transaction costs*

3,577

697

4,692

Non-GAAP selling, general,
administration expenses

$

23,054

$

25,880

$

22,412

$

94,623

$

66,016

A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended December 31, 2020, September 30, 2020, December 31, 2019 and years ended December 31, 2020 and 2019, respectively, are set forth below:

(In thousands)

Three Months Ended

Year Ended

December
31, 2020

September
30, 2020

December
31, 2019

December
31, 2020

December
31, 2019

Research and development expenses

$

41,463

$

46,095

$

36,754

$

158,757

$

132,873

Stock-based compensation

1,949

3,569

944

9,052

944

Non-GAAP Research and
development expenses

$

39,514

$

42,526

$

35,810

$

149,705

$

131,929

_______________

*Non-capitalized transaction costs include non-recurring expenses related to preparation and filing of an S-1 registration statement in the first quarter of 2020.

Reclassification Adjustments Impacting Prior Periods

During the year ended December 31, 2020, we reclassified a portion of our property, plant and equipment in machinery and equipment to inventory, as part of our standardization of accounting policies across entities, for inventory and property, plant and equipment. These reclassifications impacted our consolidated balance sheets, consolidated statements of operations and consolidated statements of cash flows, as set forth below:

(In thousands)

December 31,
2019

As Reported

Reclassification

December 31,
2019

As Adjusted

Balance Sheet

Inventories

$

26,817

$

5,038

$

31,855

Total Current assets

536,671

5,038

541,709

Property, plant and equipment, net

49,333

(5,038

)

44,295

Total assets

605,546

605,546

Statement of Cash Flows - for the year ended

(Gain) loss on disposal of property, plant and equipment

(38

)

(517

)

(555

)

Inventories

(3,528

)

(5,038

)

(8,566

)

Net cash used in operating activities

(203,556

)

(5,555

)

(209,111

)

Capital expenditures

(19,411

)

5,555

(13,856

)

Cash (used in) provided by investing activity

(19,411

)

5,555

(13,856

)

Net increase in cash and cash equivalents

$

411,353

$

$

411,353

(In thousands)

September 30,
2020

As Reported

Reclassification

September 30,
2020

As Adjusted

Statement of Operations and Comprehensive Loss - for the three months ended

Research and development expenses

$

46,243

$

(148

)

$

46,095

Operating Loss

(77,179

)

148

(77,031

)

Loss before income taxes

(76,910

)

148

(76,762

)

Net Loss

(76,950

)

148

(76,802

)

Total comprehensive loss

$

(76,902

)

$

148

$

(76,754

)

Statement of Cash Flows - for the three months ended

Net loss

$

(76,950

)

$

148

$

(76,802

)

Depreciation and amortization

2,677

(148

)

2,529

Inventories

3,457

(275

)

3,182

Net cash used in operating activities

(54,701

)

(275

)

(54,976

)

Capital expenditures

(3,996

)

275

(3,721

)

Cash (used in) provided by investing activity

(3,996

)

275

(3,721

)

Net increase in cash and cash equivalents

$

381,665

$

$

381,665

For media inquiries:

Aleanna Crane – Vice President, Communications

[email protected]

For investor relations inquiries:

Seth Zaslow – Vice President, Investor Relations

[email protected]

Source: Virgin Galactic Holdings, Inc.

Categories

Business Wire Press Releases

Next Articles